欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0362/001
药品名称Sibefil 25 mg chewable tablets
活性成分
    • sildenafil citrate 25.0 mg
剂型Chewable tablet
上市许可持有人PharmSol Europe Limited The Victoria Centre Unit 2, Lower Ground Floor, Valletta Road, Mosta MST 9012, MALTA
参考成员国 - 产品名称Malta (MT)
Sibefil 25 mg chewable tablets
互认成员国 - 产品名称
    • Austria (AT)
      Sibefil 25 mg Kautabletten
许可日期2021/01/20
最近更新日期2023/01/05
药物ATC编码
    • G04BE03 sildenafil
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase